The operation in Kabul, Afghanistan, is emerging as a key participant in the global supply chain for Abacavir Sulphate API. This Afghan manufacturing potential represents a considerable step beyond for the Afghan pharmaceutical market and presents a valuable opportunity to lower need on outside supp